Regulation of Cholesterol Sulfotransferase SULT2B1b by Hepatocyte Nuclear Factor 4α Constitutes a Negative Feedback Control of Hepatic Gluconeogenesis

REFERENCES

• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 2008. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589. https://doi.org/10.1056/NEJMoa0806470.
   PubMed Web of Science ®Google Scholar
• Kahn SE, Cooper ME, Del Prato S. 2014. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083. https://doi.org/10.1016/S0140-6736(13)62154-6.
   PubMed Web of Science ®Google Scholar
• Moore MC, Coate KC, Winnick JJ, An Z, Cherrington AD. 2012. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr 3:286–294. https://doi.org/10.3945/an.112.002089.
   PubMed Web of Science ®Google Scholar
• Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131–138. https://doi.org/10.1038/35093050.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. 2008. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet 23:2–7. https://doi.org/10.2133/dmpk.23.2.
   PubMed Web of Science ®Google Scholar
• Shi X, Cheng Q, Xu L, Yan J, Jiang M, He J, Xu M, Stefanovic-Racic M, Sipula I, O'Doherty RM, Ren S, Xie W. 2014. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4alpha. Mol Cell Biol 34:485–497. https://doi.org/10.1128/MCB.01094-13.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423:550–555. https://doi.org/10.1038/nature01667.
   PubMed Web of Science ®Google Scholar
• Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, Spiegelman BM. 2003. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A 100:4012–4017. https://doi.org/10.1073/pnas.0730870100.
   PubMed Web of Science ®Google Scholar
• Xie X, Liao H, Dang H, Pang W, Guan Y, Wang X, Shyy JY, Zhu Y, Sladek FM. 2009. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs. Mol Endocrinol 23:434–443. https://doi.org/10.1210/me.2007-0531.
   PubMed Web of Science ®Google Scholar
• Rizza RA. 2010. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes 59:2697–2707. https://doi.org/10.2337/db10-1032.
   PubMed Web of Science ®Google Scholar
• Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. 1992. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90:1323–1327.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Katsura S, Ito R, Hashiba W, Sekine H, Fujiki R, Kato S. 2011. Multiple post-translational modifications in hepatocyte nuclear factor 4alpha. Biochem Biophys Res Commun 410:749–753. https://doi.org/10.1016/j.bbrc.2011.06.033.
   PubMed Web of Science ®Google Scholar
• Thakran S, Sharma P, Attia RR, Hori RT, Deng X, Elam MB, Park EA. 2013. Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone. J Biol Chem 288:807–818. https://doi.org/10.1074/jbc.M112.437970.
   PubMed Web of Science ®Google Scholar
• Soutoglou E, Katrakili N, Talianidis I. 2000. Acetylation regulates transcription factor activity at multiple levels. Mol Cell 5:745–751. https://doi.org/10.1016/S1097-2765(00)80253-1.
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Boles JW. 1997. Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J 11:404–418. https://doi.org/10.1096/fasebj.11.6.9194521.
   PubMed Web of Science ®Google Scholar
• Gong H, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka MJ, Song WC, Cheng SY, Xie W. 2007. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 21:1781–1790. https://doi.org/10.1210/me.2007-0187.
   PubMed Web of Science ®Google Scholar
• Lee JH, Gong H, Khadem S, Lu Y, Gao X, Li S, Zhang J, Xie W. 2008. Androgen deprivation by activating the liver X receptor. Endocrinology 149:3778–3788. https://doi.org/10.1210/en.2007-1605.
   PubMed Web of Science ®Google Scholar
• Saini SP, Sonoda J, Xu L, Toma D, Uppal H, Mu Y, Ren S, Moore DD, Evans RM, Xie W. 2004. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Pharmacol 65:292–300. https://doi.org/10.1124/mol.65.2.292.
   PubMed Web of Science ®Google Scholar
• Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, Kellum J, Warnick R, Contos MJ, Sanyal AJ. 2012. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab 15:665–674. https://doi.org/10.1016/j.cmet.2012.04.004.
   PubMed Web of Science ®Google Scholar
• Falany CN, He D, Dumas N, Frost AR, Falany JL. 2006. Human cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization. J Steroid Biochem Mol Biol 102:214–221. https://doi.org/10.1016/j.jsbmb.2006.09.011.
   PubMed Web of Science ®Google Scholar
• Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. 2007. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab 5:73–79. https://doi.org/10.1016/j.cmet.2006.11.012.
   PubMed Web of Science ®Google Scholar
• Bai Q, Zhang X, Xu L, Kakiyama G, Heuman D, Sanyal A, Pandak WM, Yin L, Xie W, Ren S. 2012. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. Metabolism 61:836–845. https://doi.org/10.1016/j.metabol.2011.11.014.
   PubMed Web of Science ®Google Scholar
• Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, Wakil SJ, Stevens RD, Ilkayeva O, Newgard CB, Chan L, Moore DD. 2009. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci U S A 106:18831–18836. https://doi.org/10.1073/pnas.0909731106.
   PubMed Web of Science ®Google Scholar
• Yuan X, Ta TC, Lin M, Evans JR, Dong Y, Bolotin E, Sherman MA, Forman BM, Sladek FM. 2009. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS One 4:e5609. https://doi.org/10.1371/journal.pone.0005609.
   PubMed Web of Science ®Google Scholar
• Kiselyuk A, Lee SH, Farber-Katz S, Zhang M, Athavankar S, Cohen T, Pinkerton AB, Ye M, Bushway P, Richardson AD, Hostetler HA, Rodriguez-Lee M, Huang L, Spangler B, Smith L, Higginbotham J, Cashman J, Freeze H, Itkin-Ansari P, Dawson MI, Schroeder F, Cang Y, Mercola M, Levine F. 2012. HNF4alpha antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. Chem Biol 19:806–818. https://doi.org/10.1016/j.chembiol.2012.05.014.
   PubMedGoogle Scholar
• Fang B, Mane-Padros D, Bolotin E, Jiang T, Sladek FM. 2012. Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. Nucleic Acids Res 40:5343–5356. https://doi.org/10.1093/nar/gks190.
   PubMed Web of Science ®Google Scholar
• Sone H, Shimano H, Sakakura Y, Inoue N, Amemiya-Kudo M, Yahagi N, Osawa M, Suzuki H, Yokoo T, Takahashi A, Iida K, Toyoshima H, Iwama A, Yamada N. 2002. Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. Am J Physiol Endocrinol Metab 282:E222–E230. https://doi.org/10.1152/ajpendo.00189.2001.
   PubMed Web of Science ®Google Scholar
• Jiang M, He J, Kucera H, Gaikwad NW, Zhang B, Xu M, O'Doherty RM, Selcer KW, Xie W. 2014. Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms. J Biol Chem 289:8086–8097. https://doi.org/10.1074/jbc.M113.535914.
   PubMed Web of Science ®Google Scholar
• Cho YS, Chen CH, Hu C, Long J, Ong RT, Sim X, Takeuchi F, Wu Y, Go MJ, Yamauchi T, Chang YC, Kwak SH, Ma RC, Yamamoto K, Adair LS, Aung T, Cai Q, Chang LC, Chen YT, Gao Y, Hu FB, Kim HL, Kim S, Kim YJ, Lee JJ, Lee NR, Li Y, Liu JJ, Lu W, Nakamura J, Nakashima E, Ng DP, Tay WT, Tsai FJ, Wong TY, Yokota M, Zheng W, Zhang R, Wang C, So WY, Ohnaka K, Ikegami H, Hara K, Cho YM, Cho NH, Chang TJ, Bao Y, Hedman AK, Morris AP, McCarthy MI, DIAGRAM Consortium; MuTHER Consortium, Takayanagi R, Park KS, Jia W, Chuang LM, Chan JC, Maeda S, Kadowaki T, Lee JY, Wu JY, Teo YY, Tai ES, Shu XO, Mohlke KL, Kato N, Han BG, Seielstad M. 2011. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44:67–72. https://doi.org/10.1038/ng.1019.
   PubMed Web of Science ®Google Scholar
• Johansson S, Raeder H, Eide SA, Midthjell K, Hveem K, Sovik O, Molven A, Njolstad PR. 2007. Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians. Diabetes 56:3112–3117. https://doi.org/10.2337/db07-0513.
   PubMed Web of Science ®Google Scholar
• Yang X, Xu Y, Guo F, Ning Y, Zhi X, Yin L, Li X. 2013. Hydroxysteroid sulfotransferase SULT2B1b promotes hepatocellular carcinoma cells proliferation in vitro and in vivo. PLoS One 8:e60853. https://doi.org/10.1371/journal.pone.0060853.
   Google Scholar
• Vickman RE, Crist SA, Kerian K, Eberlin L, Cooks RG, Burcham GN, Buhman KK, Hu CD, Mesecar AD, Cheng L, Ratliff TL. 2016. Cholesterol sulfonation enzyme, SULT2B1b, modulates AR and cell growth properties in prostate cancer. Mol Cancer Res 14:776–786. https://doi.org/10.1158/1541-7786.MCR-16-0137.
   PubMed Web of Science ®Google Scholar
• Wang F, Beck-Garcia K, Zorzin C, Schamel WW, Davis MM. 2016. Inhibition of T cell receptor signaling by cholesterol sulfate, a naturally occurring derivative of membrane cholesterol. Nat Immunol 17:844–850. https://doi.org/10.1038/ni.3462.
   PubMed Web of Science ®Google Scholar
• Hwang-Verslues WW, Sladek FM. 2010. HNF4alpha–role in drug metabolism and potential drug target? Curr Opin Pharmacol 10:698–705. https://doi.org/10.1016/j.coph.2010.08.010.
   PubMed Web of Science ®Google Scholar
• Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI. 2000. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49:2063–2069. https://doi.org/10.2337/diabetes.49.12.2063.
   PubMed Web of Science ®Google Scholar
• Yin L, Ma H, Ge X, Edwards PA, Zhang Y. 2011. Hepatic hepatocyte nuclear factor 4alpha is essential for maintaining triglyceride and cholesterol homeostasis. Arterioscler Thromb Vasc Biol 31:328–336. https://doi.org/10.1161/ATVBAHA.110.217828.
   PubMed Web of Science ®Google Scholar